| NCT ID | NCT02178722 |
| Title | A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK-3475 in Combination With INCB024360 in Subjects With Selected Solid Tumors and Advanced NSCLC (INCB 24360-202 / MK-3475-037 / KEYNOTE-037) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | yes |
| Sponsors | Incyte Corporation |
| Indications |
renal pelvis transitional cell carcinoma ureter transitional cell carcinoma urethra transitional cell carcinoma |
| Therapies | |
| Age Groups: | adult |